Market Tracker

07/29 5:16pm ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1305
Delayed Data
As of Jul 29
 +0.003 / +2.35%
Today’s Change
0.06
Today|||52-Week Range
0.20
+62.11%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.13
Today’s open0.14
Day’s range0.13 - 0.14
Volume607,959
Average volume (3 months)599,655
Market cap$33.7M
Dividend yield--
Data as of 4:02pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.05-2.91%
NVGNNovogen Ltd-0.02-1.06%
PPHMPPeregrine Pharmaceut...+0.66+2.97%
PULMPulmatrix Inc-0.05-2.30%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
General Counsel
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts